0
Reviews
Targeting cardiovascular medication adherence interventions
Sarah L. Cutrona, MD, MPH; Niteesh K. Choudhry, MD, PhD; Michael A. Fischer, MD, MS; Amber D. Servi, BA; Margaret Stedman, PhD, MPH; Joshua N. Liberman, PhD; Troyen A. Brennan, MD, JD; William H. Shrank, MD, MSHS
J Am Pharm Assoc (2003) 2012;52:381-397. doi:10.1331/JAPhA.2012.10211

Abstract

Objectives  To determine whether adherence interventions should be administered to all medication takers or targeted to nonadherers.

Data sources and study selection  Systematic search (Medline and Embase, 1966–2009) of randomized controlled trials of interventions to improve adherence to medications for preventing or treating cardiovascular disease or diabetes.

Data extraction  Articles were classified as (1) broad interventions (targeted all medication takers), (2) focused interventions (targeted nonadherers), or (3) dynamic interventions (administered to all medication takers; real-time adherence information targets nonadherers as intervention proceeds). Cohen's d effect sizes were calculated.

Data synthesis  We identified 7,190 articles; 59 met inclusion criteria. Broad interventions were less likely (18%) to show medium or large effects compared with focused (25%) or dynamic (32%) interventions. Of the 33 dynamic interventions, 6 used externally generated adherence data to target nonadherers. Those with externally generated data were less likely to have a medium or large effect (20% vs. 34.8% self-generated data).

Conclusion  Adherence interventions targeting nonadherers are heterogeneous but may have advantages over broad interventions. Dynamic interventions show promise and require further study.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Institute of Medicine. 100 initial priority topics for comparative effectiveness research. Accessed at www.iom.edu/∼/media/Files/Report%20Files/2009/ComparativeEffectivenessResearchPriorities/Stand%20Alone%20List%20of%20100%20CER%20Priorities%20-%20for%20web.ashx, June 8,  2010.
 
Rasmussen JN, Chong A, Alter DA.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–86.[CrossRef]
 
New England Healthcare Institute. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. Accessed at www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease, May 27,  2010.
 
Kripalani S, Yao X, Haynes R. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167:540–50.[CrossRef]
 
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.[CrossRef]
 
Cohen J. Statistical power analysis for the behavioral sciences. New York:  Lawrence Erlbaum Associates;  1988.
 
Dunlap W, Cortina J, Vaslow J, Burke M. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods. 1996;1:170–7.[CrossRef]
 
Hedges L, Olkin I. Statistical methods for meta-analysis.  San Diego, CA:  Academic Press;  1985.
 
Higgins JP, Thompson SG.  Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.[CrossRef]
 
Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265–8.[CrossRef]
 
Rosen MI, Rigsby MO, Salahi JT, et al. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther. 2004;42:409–22.[CrossRef]
 
Saunders LD, Irwig LM, Gear JS, Ramushu DL.  A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Med Care. 1991;29:669–78.[CrossRef]
 
Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003;60:1123–9.
 
Avanzini F, Corsetti A, Maglione T, et al. Simple, shared guidelines raise the quality of antihypertensive treatment in routine care. Am Heart J. 2002;144:726–32.
 
Birtwhistle RV, Godwin MS, Delva MD, et al. Randomised equivalence trial comparing three and six months of follow up of patients with hypertension by family practitioners. BMJ. 2004;328:204.[CrossRef]
 
Christensen A, Christrupa LL, Fabriciusb PE, et al. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens. 2010;28:194–200.[CrossRef]
 
Dusing R, Handrock R, Klebs S, et al. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens. 2009;27:894–901.[CrossRef]
 
Emmett CL, Montgomery AA, Peters TJ, Fahey T. Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. Br J Gen Pract. 2005;55:551–3.
 
Hamet P, Campbell N, Curnew G, et al. Avapromise: a randomized clinical trial for increasing adherence through behavioural modification in essential hypertension. Exp Clin Cardiol. 2003;7:165–72.
 
Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC.  Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm. 1979;36:1321–5.
 
Johnson AL, Taylor DW, Sackett DL, et al. Self-recording of blood pressure in the management of hypertension. Can Med Assoc J. 1978;119:1034–9.
 
Kirscht JP, Kirscht JL, Rosenstock IM.  A test of interventions to increase adherence to hypertensive medical regimens. Health Education Quarterly. 1981;8:261–72.[CrossRef]
 
Logan AG, Milne BJ, Achber C, et al. Work-site treatment of hypertension by specially trained nurses: controlled trial. Lancet. 1979;2:1175–8.[CrossRef]
 
Lopez Cabezas C, Falces Salvador C, Cubi Quadrada D, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp. 2006;30:328–42.[CrossRef]
 
Mann DM, Ponieman D, Montori VM, et al. The statin choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80:138–40.[CrossRef]
 
Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006;24:169–75.[CrossRef]
 
Mehos BM, Saseen JJ, MacLaughlin EJ.  Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20:1384–9.[CrossRef]
 
Morisky DE, DeMuth NM, Field-Fass M, et al. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q. 1985;12:35–50.[CrossRef]
 
Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169:1560–8.[CrossRef]
 
Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm. 1995;52:2196–9.
 
Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004;17:921–7.
 
Sackett DL, Gibson ES, Taylor DW, et al. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–7.[CrossRef]
 
Sclar DA, Chin A, Skaer TL, et al. Effect of health-education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13:489–95.
 
Smith DH, Kramer JM, Perrin N, et al. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008;168:477–83.[CrossRef]
 
Stewart A, Noakes T, Eales C, et al. Adherence to cardiovascular risk factor modification in patients with hypertension. Cardiovasc J S Afr. 2005;16:102–7.
 
Takala J. Screening, treatment and adherence to treatment for hypertension. Scand J Prim Health Care. 1983;1:114–9.[CrossRef]
 
van Onzenoort HA, Verberk WJ, Kroon AA, et al. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. J Hypertens. 2010;28:622–7.[CrossRef]
 
Yilmaz MB, Pinar M, Naharci I, et al. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther. 2005;19:437–40.[CrossRef]
 
Antonicelli R, Testarmata P, Spazzafumo L, et al. Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare. 2008;14:300–5.[CrossRef]
 
Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. Int J Pharm Pract. 2000;8:165–75.[CrossRef]
 
Bouvy ML, Heerdink ER, Urquhart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9:404–11.[CrossRef]
 
Edworthy SM, Baptie B, Galvin D, et al. Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial. Can J Cardiol. 2007;23:1066–72.[CrossRef]
 
Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE.  Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20:410–6.[CrossRef]
 
Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension: impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285–92.[CrossRef]
 
Guthrie RM.  The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the First Myocardial Infarction Risk Reduction Program. Clin Ther. 2001;23:970–80.[CrossRef]
 
Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966–72.[CrossRef]
 
Jaffray M, Bond C, Watson M, et al. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007;24:189–200.[CrossRef]
 
Krantz MJ, Havranek EP, Haynes DK, et al. Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study. J Card Fail. 2008;14:303–9.[CrossRef]
 
Logan AG, Milne BJ, Flanagan PT, Haynes RB.  Clinical effectiveness and cost-effectiveness of monitoring blood-pressure of hypertensive employees at work. Hypertension. 1983;5:828–36.[CrossRef]
 
Odegard PS, Goo A, Hummel J, et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.[CrossRef]
 
Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21:1137–43.[CrossRef]
 
Piette JD, Weinberger M, McPhee SJ, et al. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108:20–7.[CrossRef]
 
Planas LG, Crosby KM, Mitchell KD, Farmer KC.  Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164–70.[CrossRef]
 
Sadik A, Yousif M, McElnay JC.  Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60:183–93.[CrossRef]
 
Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile-acid sequestrant therapy. Ann Pharmacother. 1994;28:29–35.
 
Schroeder K, Fahey T, Hollinghurst S, Peters TJ.  Nurse-led adherence support in hypertension: a randomized controlled trial. Fam Pract. 2005;22:144–51.[CrossRef]
 
Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38:574–85.
 
Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023–8.[CrossRef]
 
Stacy JN, Schwartz SM, Ershoff D, Shreve MS.  Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12:241–54.[CrossRef]
 
Tsuyuki RT, Fradette M, Johnson JA, et al. A multicenter disease management program for hospitalized patients with heart failure. J Card Fail. 2004;10:473–80.[CrossRef]
 
Varma S, McElnay JC, Hughes CM, et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19:860–9.[CrossRef]
 
Vivian EM.  Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22:1533–40.[CrossRef]
 
Johnson SS, Driskell MM, Johnson JL, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9:102–14.[CrossRef]
 
Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146:714–25.[CrossRef]
 
Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Prim Care Diabetes. 2008;2:31–7.[CrossRef]
 
Robinson JD, Segal R, Lopez LM, Doty RE.  Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44:88–96.[CrossRef]
 
Tamblyn R, Reidel K, Huang A, et al. Increasing the detection and response to adherence problems with cardiovascular medication in primary care through computerized drug management systems: a randomized controlled trial. Med Decis Making. 2010;30:176–88.[CrossRef]
 
Vrijens B, Belmans A, Matthys K, et al. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006;15:115–21.[CrossRef]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints